Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with cancer: a systematic review.
Parra A, Hernández C, Prieto-Pinto L. Parra A, et al. Among authors: prieto pinto l. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(9):1017-1026. doi: 10.1080/14737167.2023.2249232. Epub 2023 Sep 4. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37665685 Free article. Review.
Burden of disease of spinal muscular atrophy linked to chromosome 5q (5q-SMA) in Colombia.
Gil-Rojas Y, Suárez-Obando F, Amaya-Granados D, Prieto-Pinto L, Samacá-Samacá D, Ortiz B, Hernández F. Gil-Rojas Y, et al. Among authors: prieto pinto l. Expert Rev Pharmacoecon Outcomes Res. 2023 Jul-Dec;23(6):671-682. doi: 10.1080/14737167.2023.2206569. Epub 2023 Apr 28. Expert Rev Pharmacoecon Outcomes Res. 2023. PMID: 37096565
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable or metastatic melanoma with BRAF V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: prieto pinto l. Dermatol Ther. 2020 Aug 5:e14135. doi: 10.1111/dth.14135. Online ahead of print. Dermatol Ther. 2020. PMID: 32761749 Review.
Efficacy and safety of dabrafenib-trametinib in the treatment of unresectable advanced/metastatic melanoma with BRAF-V600 mutation: A systematic review and network meta-analysis.
Garzón-Orjuela N, Prieto-Pinto L, Lasalvia P, Herrera D, Castrillón J, González-Bravo D, Castañeda-Cardona C, Rosselli D. Garzón-Orjuela N, et al. Among authors: prieto pinto l. Dermatol Ther. 2020 Mar;33(2):e13145. doi: 10.1111/dth.13145. Epub 2019 Nov 14. Dermatol Ther. 2020. PMID: 31664762 Review.
11 results